STAT3 and cancer: Cancer migration and angiogenesis could also be inhibited by erianin through modulating the expression of ERα, p-ERK1/2, MMP2, MMP9, TIMP1/2, COX-2, HIF-1α, and IL-6, or the activation of JAK2/STAT3 [187].